References
- Esler M, Lambert E, Alvarenga M, Socratous F, Richards J, Barton D, Pier C, Brenchley C, Dawood T, Hastings J, Guo L, Haikerwal D, Kaye D, Jennings G, Kalff V, Kelly V, Wiesner G, Lambert G. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: Reduction by a selective serotonin reuptake inhibitor. Stress 2007; 10(3)295–304
- Hauger RL, Scheinin M, Siever LJ, Linnoila M, Potter WZ. Dissociation of norepinephrine turnover from alpha-2 responses after clorgiline. Clin Pharmacol Ther 1988; 43(1)32–38
- Hood SD, Argyropoulos SV, Nutt DJ. New directions in the treatment of anxiety disorders. Expert Opin Ther Patents 2003; 13(4)401–424
- Hood SD, Bell CJ, Nutt DJ. Acute tryptophan depletion. Part I: Rationale and methodology. Aust N Z J Psychiatry 2005; 39(7)558–564
- Nash J, Sargent P, Rabiner E, Hood SD, Argyropoulos SV, Grasby P, et al. Altered 5-HT1A binding in panic disorder demonstrated by PET scanning. J Psychopharmacol 2003; 17(3)A30